Ordering Publications

To order a hard copy of any of the publications listed below from UCLA ISAP, send the article number (found at the end of the reference, for example "12.1"), the article author/title, and your postal address to:

Kris Langabeer
UCLA Integrated Substance Abuse Programs
1640 S. Sepulveda Blvd., Ste. 200
Los Angeles, CA 90025-7535

Your first 5 articles ordered per year are free, but additional articles are $1 per reprint. Checks should be made out to "UC Regents." Purchase orders will not be accepted for orders under $25.

Publications List (L-M)

(A list of all publications is available as an .rtf file).

Lang, A. R., Pelham, W. E., Atkeson, B. M., & Murphy, D. A. (1999). Effects of alcohol intoxication on parenting behavior in interactions with child confederates exhibiting normal or deviant behaviors. Journal of Abnormal Child Psychology, 27(3), 177-189. (02.16)

Lehman, W. E. K., Farabee, D., & Bennett, J. B. (1998). Perceptions and correlates of co-worker substance abuse. Employee Assistance Quarterly, 13(4), 1-22. (22.2)

Leukefeld, C. G., Farabee, D., McDermeit, M., Dennis, M. L., Wechsberg, W. M., Inciardi, J. A., Surratt, H. L., Compton, W. M., Cottler, L. B., Klein, H., Hoffman, J. A., Desmond, D., & Logan, T. K. (2001). Real and perceived HIV risk by population density: An exploratory examination. Journal of Drug Issues, 31(4), 889-900. (01.86)

Leukefeld, C. G., Gallego, M. A., & Farabee, D. (1997). Drugs, crime, and HIV. Substance Use and Misuse, 32(6), 749-756. (06.30)

Leukefeld, C. G., Logan, T. K., Martin, S. S., Purvis, R. T., & Farabee, D. (1998). A health services use framework for drug-abusing offenders. American Behavioral Scientist, 41(8), 1123-1135. (03.13)

Levin, L., Henry-Reid, L., Murphy, D. A., Peralta, L., Sarr, M., Ma, Y., & Rogers, A. S. (2001). Incident pregnancy rates in HIV infected and HIV uninfected at-risk adolescents. Journal of Adolescent Health, 29(Suppl 3), 101-108. (01.68)

Levin, S., Sinclair, S., Veniegas, R. C., & Taylor, P. L. (2002). Perceived discrimination in the context of multiple group memberships. Psychological Sciences, 13(6 ), 557-560. (09.32)

Lightfoot, M., Robin, L., Rotheram-Borus, M. J., Murphy, D. A., Diaz, M. M., Lehane, J., & Rosen, L. R. (2000). Lifestyle choices of parents living with AIDS: differences in health behavior and mental health. AIDS and Behavior, 4(3), 253-260. (01.62)

Lightfoot, M., Rotheram-Borus, M. J., Towns, B., Cline, T. R., Webber, D., Murphy, D. A., & Tsai, L. F. (2001). Religious groups as diffusers of HIV antibody testing and prevention messages. Journal of Community Psychology, 29(4), 459-472. (01.69)

Ling, W. (2002). Cynthia's dilemma. American Journal of Bioethics, 2(2), 55-56. (18.101)

Ling, W., Charuvastra, C., Collins, J. F., Batki, S., Brown, L. S. J., Kintaudi, P., Wesson, D. R., McNicholas, L., Tusel, D. J., Malkerneker, U., Renner, J. A. J., Santos, E., Casadonte, P., Fye, C., Stine, S., Wang, R. I. H., & Segal, D. (1998). Buprenorphine maintenance treatment of opiate dependence: A multicenter, randomized clinical trial. Addiction, 93(4), 475-486. (29.18)

Ling, W., Rawson, R., & Anglin, M. D. (2003). Pharmacology, practice, and politics: A tale of two opiate pharmacotherapies. In: J. L. Sorenson, R. Rawson, J. Guydish, & J. E. Zweben (Eds.), Drug abuse treatment through collaboration:Practice and research partnerships that work (pp. 107-119). Washington, D.C.: American Psychological Association. (29.22)

Ling, W., & Shoptaw, S. (1997). Integration of research in pharmacotherapy for addictive disease: Where are we? Where are we going? Journal of Addictive Diseases, 16(4), 83-102. (18.26)

Ling, W., Shoptaw, S., & Majewska, D. (1998). Baclofen as a cocaine anti-craving medication: a preliminary clinical study. Neuropsychopharmacology, 18(5), 403-404. (04.20)

Ling, W., Shoptaw, S., Wesson, D. R., Rawson, R., Compton, P. A., & Klett, J. (1997). Treatment Effectiveness Score as an outcome measure in clinical trials. In: Medication development for the treatment of cocaine dependence in clinical efficacy trials (NIDA Research Monograph 175, pp. 208-220). Rockville, MD: National Institute on Drug Abuse. (13.28)

Ling, W., & Smith, D. (2002). Buprenorphine: blending practice and research. Journal of Substance Abuse Treatment, 23(2), 87-92. (29.25)

Ling, W., & Wesson, D. R. (2003). Clinical efficacy of buprenorphine: comparisons to methadone and placebo. Drug and Alcohol Dependence, 70(2, Suppl. 1), S49-S57. (29.23)

Liu, X., Matochik, J. A., Cadet, J. L., & London, E. D. (1998). Smaller volume of prefrontal lobe in polysubstance abusers: a magnetic resonance imaging study. Neuropsychopharmacology, 18(4), 243-252. (30.7)

Liu, X., Vaupel, D. B., Grant, S., & London, E. D. (1998). Effect of cocaine-related environmental stimuli on the spontaneous electroencephalogram in polydrug abusers. Neuropsychopharmacology, 19(1), 10-17. (30.8)

Logan, T. K., Leukefeld, C. G., & Farabee, D. (1998). Sexual and drug use behaviors among women crack users: implications for prevention. AIDS Education and Prevention, 10(4), 327-340. (04.37)

Lombardi, E. L. (2001). Enhancing transgender health care. American Journal of Public Health, 91(6), 869-872. (14.11)

Lombardi, E. L., & Van Servellen, G. (2000). Building culturally sensitive substance use prevention and treatment programs for transgendered populations. Journal of Substance Abuse Treatment, 19(3), 291-296. (14.09)

Lombardi, E. L., & Van Servellen, G. (2000). Correcting deficiencies in HIV/AIDS care for transgendered individuals. Journal of the Association of Nurses in AIDS Care, 11(5), 61-69. (01.55)

London, E. D., Ernst, M., Grant, S., Bonson, K. R., & Weinstein, A. (2000). Orbitofrontal cortex and human drug abuse: functional imaging. Cerebral Cortex, 10(3), 334-342. (30.2)

Longshore, D. (1992). AIDS education for drug users: Existing research and new directions. Journal of Drug Issues, 22(1), 1-16. (01.12)

Longshore, D. (1990). AIDS education for three high-risk populations. Special issue: Evaluation of AIDS prevention and education programs. Evaluation and Program Planning, 13(1), 67-72. (01.4)

Longshore, D. (2001). Commentary. In: Handbook of program development for health behavior research and practice (pp. 387-390). Thousand Oaks, CA: Sage Publications. (18.44)

Longshore, D. (1998). Desire for help among drug-using Mexican-American arrestees. Substance Use and Misuse, 33(6), 1387-1407. (09.17)

Longshore, D. (1998). Drug problem recognition among Mexican American drug-using arrestees. Hispanic Journal of Behavioral Sciences, 20(2), 270-275. (09.15)

Longshore, D. (1999). Help-seeking by African American drug users: a prospective analysis. Addictive Behaviors, 24(5), 683-686. (09.23)

Longshore, D. (1992). HIV/AIDS and drug use epidemiology in California: Directions for research and disease surveillance. Los Angeles, CA: University of California, Los Angeles, Drug Abuse Research Center. (01.39)

Longshore, D. (1990). A model of AIDS education. In: L. Leviton, A. M. Hegedus, & A. Kubrin (Eds.), Evaluating AIDS prevention: Contributions of multiple disciplines (pp. 63-73). San Francisco: Jossey-Bass. (01.6)

Longshore, D. (1996). Prevalence and circumstances of drug injection at Los Angeles shooting galleries. Crime and Delinquency, 42(1), 21-35. (12.24)

Longshore, D. (1989). Reaching populations at higher risk for AIDS. AIDS and Public Policy Journal, 4(2), 101-105. (01.5)

Longshore, D. (1998). Self-control and criminal activity: a prospective test of the general theory of crime. Social Problems, 45(1), 102-113. (06.32)

Longshore, D. (1997). Treatment motivation among Mexican American drug using arrestees. Hispanic Journal of Behavioral Sciences, 19(2), 214-229. (09.13)

Longshore, D., & Anglin, M. D. (1996). HIV incidence among injection drug users [letter]. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 11(3), 308-309. (01.28)

Longshore, D., & Anglin, M. D. (1994). HIV prevalence and incidence among injection drug users in Los Angeles. Journal of Acquired Immune Deficiency Syndromes, 7(7), 738-739. (01.25)

Longshore, D., & Anglin, M. D. (1990). HIV seroprevalence and AIDS risk among drug users in Los Angles County. Los Angeles: University of California, Los Angeles, Drug Abuse Research Center. (01.41)

Longshore, D., & Anglin, M. D. (1991). HIV transmission and risk behavior among drug users in Los Angeles County. (Contract 759408). Los Angeles: UCLA Drug Abuse Research Center. (01.8)

Longshore, D., & Anglin, M. D. (1994). HIV transmission and risk behavior among drug users in Los Angeles County: 1994 update. Los Angeles, CA: UCLA Drug Abuse Research Center. (01.38)

Longshore, D., & Anglin, M. D. (1995). Intentions to share injection paraphernalia: An empirical test of the AIDS risk reduction model among injection drug users. International Journal of the Addictions, 30(3), 305-321. (01.24)

Longshore, D., & Anglin, M. D. (1995). Number of sex partners and crack cocaine use: Is crack an independent marker for HIV risk behavior? Journal of Drug Issues, 25(1), 1-10. (01.22)

Longshore, D., & Anglin, M. D. (1992). Seroprevalence stable and seroconversions rare among injection drug users in Los Angeles (correspondence). Journal of Acquired Immune Deficiency Syndromes, 5(2), 212-213. (01.13)

Longshore, D., Anglin, M. D., Annon, K., Boyle, K., & Cason, G. (1991). HIV seroprevalence and risk behaviors: Report from Los Angeles. International Working Group on AIDS and Drug Use, 5(2), 44-45. (01.9)

Longshore, D., Anglin, M. D., Annon, K., Fukui, P., & Asch, J. (1992). Detection of HIV-1 antibody in urine specimens in a region of low HIV-1 prevalence [letter]. Journal of Acquired Immune Deficiency Syndromes, 5(9), 947-949. (01.14)

Longshore, D., Anglin, M. D., Annon, K., & Hsieh, S. (1993). Trends in self-reported HIV risk behavior: Injection drug users in Los Angeles. Journal of Acquired Immune Deficiency Syndromes, 6(1), 82-90. (01.17)

Longshore, D., Anglin, M. D., Henson, K. D., & Annon, K. (1993). HIV transmission and risk behavior among drug users in Los Angeles County: 1993 update. Los Angeles, CA: University of California, Los Angeles, Drug Abuse Research Center. (01.40)

Longshore, D., Anglin, M. D., & Hsieh, S. (1997). Intended sex with fewer partners: An empirical test of the AIDS risk reduction model among injection drug users. Journal of Applied Social Psychology, 27(3), 187-208. (01.29)

Longshore, D., Anglin, M. D., Hsieh, S., & Annon, K. (1993). Drug-related HIV risk behaviors and cocaine preference among injection drug users in Los Angeles. Journal of Drug Education, 23(3), 259-272. (01.19)

Longshore, D., Anglin, M. D., Hsieh, S., & Annon, K. (1993). Sexual behaviors and cocaine preference among injection drug users in Los Angeles. Journal of Drug Issues, 23(3), 363-374. (04.24)

Longshore, D., Annon, J. J., & Anglin, M. D. (1998). HIV prevalence among injection drug users in three Northern California communities. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 19(2), 200. (01.34)

Longshore, D., Annon, J. J., & Anglin, M. D. (1998). Long-term trends in self-reported HIV risk behavior: Injection drug users in Los Angeles, 1987 through 1995. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18(1), 64-72. (01.32)

Longshore, D., Bluthenthal, R. N., & Stein, M. D. (2001). Needle exchange program attendance and injection risk in Providence, Rhode Island. AIDS Education and Prevention, 13(1), 78-90. (01.54)

Longshore, D., & Grills, C. (1998). Drug problem recognition among African American drug-using arrestees. Addictive Behaviors, 23(2), 275-279. (09.20)

Longshore, D., & Grills, C. (2000). Motivating illegal drug use recovery: Evidence for a culturally congruent intervention. Journal of Black Psychology, 26(3), 288-301. (09.29)

Longshore, D., Grills, C., Anglin, M. D., & Annon, K. (1997). Desire for help among African-American drug users. Journal of Drug Issues, 27(4), 755-770. (09.18)

Longshore, D., Grills, C., Anglin, M. D., & Annon, K. (1998). Treatment motivation among African American drug-using arrestees. Journal of Black Psychology, 24(2), 126-144. (09.16)

Longshore, D., Grills, C., & Annon, K. (1999). Effects of a culturally congruent intervention on cognitive factors related to drug use-recovery. Substance Use and Misuse, 34(9), 1223-1241. (09.22)

Longshore, D., Grills, C., Annon, K., & Grady, R. (1998). Promoting recovery from drug abuse: An Africentric intervention. Journal of Black Studies, 28(3), 319-333. (09.19)

Longshore, D., & Hsieh, S. (1998). Drug abuse treatment and risky sex: Evidence for a cumulative treatment effect? American Journal of Drug and Alcohol Abuse, 24(3), 439-451. (18.62)

Longshore, D., Hsieh, S., & Anglin, M. D. (1992). AIDS knowledge and attitudes among injection drug users: The issue of reliability. AIDS Education and Prevention, 4(1), 29-40. (01.16)

Longshore, D., Hsieh, S., & Anglin, M. D. (1993). Ethnic and gender differences in drug users' perceived need for treatment. International Journal of the Addictions, 28(6), 539-558. (09.5)

Longshore, D., Hsieh, S., & Anglin, M. D. (1994). Reducing HIV risk behavior among injection drug users: Effect of methadone maintenance treatment on number of sex partners. International Journal of the Addictions, 29(6), 741-757. (01.15)

Longshore, D., Hsieh, S., Anglin, M. D., & Annon, K. (1992). Ethnic patterns in drug abuse treatment utilization. Special issue: Multicultural mental health and substance abuse services. Journal of Mental Health Administration, 19(3), 268-277. (09.6)

Longshore, D., Hsieh, S., Danila, B., & Anglin, M. D. (1993). Methadone maintenance and needle/syringe sharing. International Journal of the Addictions, 28(10), 983-996. (10.14)

Longshore, D., Prendergast, M. L., Hser, Y., & Evans, E. (2002). Evaluation of California’s Substance Abuse and Crime Prevention Act of 2000: What we need to know; what we’ve learned so far. Offender Substance Abuse Report, 2(2), 17, 25-27. (03.25)

Longshore, D., & Sanders-Phillips, K. (2000). Moral belief and drug problem recognition in three ethnic groups. Advances in Medical Sociology, 7, 177-191. (09.24)

Longshore, D., Santiago, L., & Heinzerling, K. (2003). Harm reduction/primary care program evaluation. Los Angeles, CA: University of California. (18.106)

Longshore, D., Stein, J. A., & Anglin, M. D. (1996). Ethnic differences in the psychosocial antecedents of needle/syringe disinfection. Drug and Alcohol Dependence, 42(3), 183-196. (09.12)

Longshore, D., Stein, J. A., & Anglin, M. D. (1997). Psychosocial antecedents of needle/syringe disinfection by drug users: A theory-based prospective analysis. AIDS Education and Prevention, 9(5), 442-459. (01.44)

Longshore, D., Stein, J. A., & Anglin, M. D. (1998). Psychosocial antecedents of unprotected sex by drug-using men and women. AIDS and Behavior, 2(4), 293-306. (01.33)

Longshore, D., Stein, J. A., Kowalewski, M. R., & Anglin, M. D. (1998). Psychosocial antecedents of unprotected sex by drug-using men and women. AIDS and Behavior, 2(4), 293-306. (01.47)

Longshore, D., Stein, J. A., & Turner, S. (1998). Reliability and validity of a self-control measure: Rejoinder. Criminology, 36(1), 175-182. (20.9)

Longshore, D., & Turner, S. (1998). Self-control and criminal opportunity: Cross sectional test of the general theory of crime. Criminal Justice and Behavior, 25(1), 81-98. (20.8)

Longshore, D., Turner, S., & Anglin, M. D. (1998). Effects of case management on drug users' risky sex. Prison Journal, 78(1), 6-30. (01.35)

Longshore, D., Turner, S., & Stein, J. A. (1996). Self-control in a criminal sample: An examination of construct validity. Criminology, 34(2), 209-228. (20.5)

Longshore, D., Turner, S., Wenzel, S. L., Morral, A., Harrell, A., McBride, D., Deschenes, E. P., & Iguchi, M. (2001). Drug courts: A conceptual framework. Journal of Drug Issues, 31(1), 7-25. (03.20)

Lopatko, O. V., White, J. M., Huber, A., & Ling, W. (2003). Opioid effects and opioid withdrawal during a 24 h dosing interval in patients maintained on buprenorphine. Drug and Alcohol Dependence, 69, 317-322. (29.21)

Lukas, S. E., Amass, L., Kouri, E., & Bolduc, M. (1990). Topographic brain mapping during ethanol-, marihuana-, and cocaine-induced intoxication. Touching BASIS, 7, 471-477. (02.13)

Lukas, S. E., Benedikt, R., Mendelson, J. H., Kouri, E., Sholar, M., & Amass, L. (1992). Marihuana attenuates the rise in plasma ethanol levels in human subjects. Neuropsychopharmacology, 7(1), 77-81. (02.12)

Lukas, S. E., Mendelson, J. H., Kouri, E., Bolduc, M., & Amass, L. (1990). Ethanol-induced alterations in EEG alpha activity and apparent source of the auditory p300 evoked response potential. Alcohol, 7(5), 471-477. (02.11)

Lutfy, K., & Weber, E. (1998). Tolerance develops to the antinociceptive and motor impairing effects of ACEA-1416, an NMDA receptor antagonist, in the formalin and rotarod tests in mice. Pharmacological Research, 37(4), 295-302. (20.11)

Maglione, M. A., Chao, B., & Anglin, M. D. (2000). Correlates of outpatient drug treatment drop-out among methamphetamine users. Journal of Psychoactive Drugs, 32(2), 221-228. (24.12)

Maglione, M. A., Chao, B., & Anglin, M. D. (1998). Methamphetamine abuse in California: Correlates of Injection Use. AIDS and Behavior, 2(3), 257-261. (01.46)

Maglione, M. A., Chao, B., & Anglin, M. D. (2000). Residential treatment of methamphetamine users: Correlates of drop-out from the California alcohol and drug data system (CADDS), 1994-1997. Addiction Research, 8(1). (24.13)

Maglione, M. A., Hser, Y., Boyle, K., & Anglin, M. D. (1997). Patterns and correlates of drug use among amphetamine users. Unpublished manuscript, University of California, Los Angeles, Drug Abuse Research Center: (12.25)

Marelich, W. D., Roberts, K. J., Murphy, D. A., & Callari, T. (2002). HIV/AIDS patient involvement in antiretroviral treatment decisions. AIDS Care, 14(1), 17-26. (01.70)

Margolin, A., Kleber, H. D., Avants, S. K., Konefal, J., Gawin, F. H., Stark, E., Sorensen, J., Midkiff, E., Wells, E., Jackson, T. R., Bullock, M., Culliton, P. D., Boles, S. M., & Vaughan, R. (2001). Acupuncture for the treatment of cocaine addiction - A randomized controlled trial. JAMA-Journal of the American Medical Association, 287(1), 55-63. (04.16)

Margolin, A., Kosten, T. R., Avants, S. K., Wilkins, J., Ling, W., & And Others. (1995). A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients. Drug and Alcohol Dependence, 40(2), 125-131. (04.52)

Marinelli-Casey, P., Domier, C. P., & Rawson, R. (2002). The gap between research and practice in substance abuse treatment. Psychiatric Services, 55(8), 984-987. (13.38)

Marshall, G. N., & Hser, Y. (2002). Characteristics of criminal justice and noncriminal justice clients receiving treatment for substance abuse. Addictive Behaviors, 27, 179-192. (03.18)

Matochik, J. A., Chefer, S. I., Lane, M. A., Woolf, R. I., Morris, E. D., Ingram, D. K., Roth, G. S., & London, E. D. (2000). Age-related decline in striatal volume in monkeys as measured by magnetic resonance imaging. Neurobiology of Aging, 21(4), 591-598. (30.11)

Mattick, R. P., Ali, R., Auriacombe, M., Davoli, M., Faggiano, F., Farrell, M., Ferri, M., & Ling, W. (2001). Cohrane Drugs and Alcohol Group: The development of systematic reviews of treatment outcome. Alcohol and Alcoholism, 36(2), 109-111. (13.40)

Maugh, T. H., & Anglin, M. D. (1994). Court-ordered drug treatment does work: But some approaches are more successful than others. Judges' Journal, 34(4), 10-13; 38-40. (18.23)

McAuliffe, T. L., Kelly, J. A., Sikkema, K. J., Murphy, D. A., Winett, R. A., Solomon, L. J., & Roffman, R. A. (1999). Sexual HIV risk behavior levels among young and older gay men outside of AIDS epicenters: findings of a 16-city sample. AIDS and Behavior, 3(2), 111-119. (01.71)

McCarthy, W. J., & Anglin, M. D. (1990). Narcotics addicts: Effect of family and parental risk factors on timing of emancipation, drug use onset, pre-addiction incarcerations and educational achievement. Journal of Drug Issues, 20(1), 99-123. (11.5)

McCarthy, W. J., Collins, C., & Hser, Y. (2002). Does cigarette smoking affect drug abuse treatment? Journal of Drug Issues, 32(1), 61-79. (17.6)

McCarthy, W. J., Zhou, Y., & Hser, Y. (2001). Individual change amid stable smoking patterns in polydrug users over 3 years. Addictive Behaviors, 26(1), 143-149. (17.4)

McCarthy, W. J., Zhou, Y., & Hser, Y. (2001). Psychosocial versus nicotine-only self-report measures for predicting follow-up smoking status. Journal of Behavioral Medicine, 24(1), 75-91. (17.5)

McCarthy, W. J., Zhou, Y., Hser, Y., & Collins, C. (2002). To smoke or not to smoke: impact on disability, quality of life, and illicit drug use in baseline polydrug users. Journal of Addictive Diseases, 21(2), 35-54. (17.7)

McClellan, D. S., Farabee, D., & Crouch, B. M. (1997). Early victimization, drug use, and criminality. Criminal Justice and Behavior, 24(4), 455-476. (06.29)

McGlothlin, W. H., & Anglin, M. D. (1979). Effects of closing the Bakersfield methadone clinic. In: L. S. Harris (Ed.), Problems of drug dependence 1979: Proceedings of the 41st annual scientific meeting, the Committee on Problems of Drug Dependence, Inc. (NIDA Research Monograph 27, pp. 135-141). Rockville, MD: National Institute on Drug Abuse. (10.1)

McGlothlin, W. H., & Anglin, M. D. (1981). Long-term follow-up of clients of high- and low-dose methadone programs. Archives of General Psychiatry, 38(9), 1055-1063. (10.2)

McGlothlin, W. H., & Anglin, M. D. (1981). Shutting off methadone. Costs and benefits. Archives of General Psychiatry, 38(8), 885-892. (10.3)

McGlothlin, W. H., Anglin, M. D., & Wilson, B. D. (1977). An evaluation of the California civil addicts program. (NIDA Services Research Monograph Series, DHHS Publication No. ADM 78-558). Rockville, MD: National Institute on Drug Abuse. (03.2)

McGlothlin, W. H., Anglin, M. D., & Wilson, B. D. (1977). A follow-up of admissions to the California civil addicts program. American Journal of Drug and Alcohol Abuse, 4(2), 179-199. (03.3)

McGlothlin, W. H., Anglin, M. D., & Wilson, B. D. (1978). Narcotic addiction and crime. Criminology, 16(3), 293-315. (06.1)

McGlothlin, W. H., Anglin, M. D., & Wilson, B. D. (1976). Outcome of the California civil addict commitments: 1961-1972. Drug and Alcohol Dependence, 1(3), 165-181. (03.1)

McSweeney, F. K., & Roll, J. M. (1998). Do animals satiate or habituate to repeatedly presented reinforcers? Psychonomic Bulletin and Review, 5(3), 428-442. (20.3)

McSweeney, F. K., & Roll, J. M. (1993). Responding changes systematically within sessions during conditioning procedures. Journal of the Experimental Analysis of Behavior, 60(3), 621-640. (27.5)

McSweeney, F. K., Roll, J. M., & Cannon, C. B. (1994). The generality of within-session patterns of responding: rate of reinforcement and session length. Animal Learning and Behavior, 22(3), 252-266. (20.17)

McSweeney, F. K., Weatherly, J. N., & Roll, J. M. (1995). Within-session changes in responding during concurrent schedules that employ two different operanda. Animal Learning and Behavior, 23(3), 237-244. (20.16)

McSweeney, F. K., Weatherly, J. N., Roll, J. M., & Swindell, S. (1995). Within-session patterns of responding when the operandum changes during the session. Learning and Motivation, 26(4), 403-420. (27.10)

Meil, W. M., Roll, J. M., Grimm, J. W., Lynch, A. M., See, R. E., & See, R. E. (1995). Tolerance-like attenuation to contingent and noncontingent cocaine-induced elevation of extracellular dopamine in the ventral striatum following 7 days of withdrawal from chronic treatment. Psychopharmacology, 118(3), 338-346. (27.7)

Mendelson, J. H., Lukas, S. E., Mello, N. K., Amass, L., Ellingboe, J., & Skupny, A. (1988). Acute alcohol effects on plasma estrdiol levels in women. Psychopharmacology, 94(4), 464-467. (02.14)

Messina, N., Burdon, W. M., Prendergast, M. L., & Patten, M. (2003). Assessing the needs of women in prison-based therapeutic communities. Women, Girls, and Criminal Justice, 4(3), 33-34, 46-48. (03.31)

Messina, N., Farabee, D., & Rawson, R. (2003). Treatment responsivity of cocaine-dependent patients with antisocial personality disorder to cognitive-behavioral and contingency management interventions. Journal of Consulting and Clinical Psychology, 71(2), 320-329. (04.57)

Messina, N., Nemes, S., Wish, E. D., & Wraight, B. (2001). Opening the black box: the impact of inpatient treatment services on client outcomes. Journal of Substance Abuse Treatment, 20(2), 177-183. (13.18)

Messina, N., & Prendergast, M. L. (2001). Therapeutic community treatment for women in prison: Some success, but the jury is still out. Offender Substance Abuse Report, 1(4), 49-50, 54-56. (21.28)

Messina, N., Wish, E. D., Hoffman, J. A., & Nemes, S. (2002). Antisocial personality disorder and TC treatment outcomes. American Journal of Drug and Alcohol Abuse, 28(2), 197-212. (15.13)

Messina, N., Wish, E. D., Hoffman, J. A., & Nemes, S. (2001). Diagnosing antisocial personality disorder among substance abusers: the SCID versus the MCMI-II. American Journal of Drug and Alcohol Abuse, 27(4), 699-717. (15.12)

Messina, N., Wish, E. D., & Nemes, S. (2000). Predictors of treatment outcomes in men and women admitted to a therapeutic community. American Journal of Drug and Alcohol Abuse, 26(2), 207-227. (14.10)

Messina, N., Wish, E. D., & Nemes, S. (1999). Therapeutic community treatment for substance abusers with antisocial personality disorder. Journal of Substance Abuse Treatment, 17(1-2), 121-128. (15.11)

Messina, N., Wish, E. D., & Nemes, S. (2001). Therapeutic community treatment may reduce future incarceration: A research note. Federal Probation, 65(3), 40-45. (06.40)

Messina, N., Wish, E. D., Nemes, S., & Wraight, B. (2000). Correlates of underreporting of post-discharge cocaine use among therapeutic community clients. Journal of Drug Issues, 30(1), 119-132. (04.22)

Mieczkowski, T., Anglin, M. D., Coletti, S., Johnson, B. D., Nadelmann, E. A., & Wish, E. D. (1992). Responding to America's drug problems: Strategies for the 1980's. Journal of Urban Affairs, 14(3,4), 337-357. (13.5)

Mintzer, M. Z., Griffiths, R. R., Contoreggi, C., Kimes, A. S., London, E. D., & Ernst, M. (2001). Effects of triazolam on brain activity during episodic memory encoding: a PET study. Neuropsychopharmacology, 25(5), 744-756. (30.5)

Miotto, K., McCann, M. J., Basch, J., Rawson, R., & Ling, W. (2002). Naltrexone and dysphoria: fact or myth? American Journal on Addictions, 11( 2), 151-160. (29.19)

Miotto, K., McCann, M. J., Rawson, R., & Frosch, D. L. (1997). Overdose, suicide attempts and death among a cohort of naltrexone-treated opioid addicts. Drug and Alcohol Dependence, 45(1-2), 131-134. (29.8)

Miotto, K., McCann, M. J., Rawson, R., Frosch, D. L., & Ling, W. (1997). Overdose, suicide attempts and death among a cohort of naltrexone-treated opioid addicts. Drug and Alcohol Dependence, 45(1-2), 131-134. (29.20)

Moody, D. E., Laycock, J. D., Spanbauer, A. C., Crouch, D. J., Foltz, R. L., Josephs, J. L., Amass, L., & Bickel, W. K. (1997). Determination of buprenorphine in human plasma by gas chromatography positive ion chemical ionization mass spectrometry and liquid chromatography tandem mass spectrometry. Journal of Analytical Toxicology, 21(6), 406-414. (29.12)

Moscicki, A. B., Durako, S. J., Houser, J., Ma, Y., Murphy, D. A., Darragh, T. M., Farhat, S., & Wilson, C. M. (2003). Human papillomavirus infection and abnormal cytology of the anus in HIV-infected and uninfected adolescents. AIDS, 17, 311-320. (01.93)

Mukhin, A. G., Gundisch, D., Horti, A. G., Koren, A. O., Tamagnan, G., Kimes, A. S., Chambers, J., Vaupel, D. B., King, S. L., Picciotto, M. R., Innis, R. B., & London, E. D. (2000). 5-iodo-a-85380, an alpha 4 beta 2 subtype-selective ligand for nicotinic acetylcholine receptors. Molecular Pharmacology, 57(3), 642-649. (30.16)

Murphy, D. A., Cantwell, C., Jordan, D. D., Lee, M. B., Cooley-Quille, M. R., & Lahey, B. B. (2000). Test-retest reliability of dominic anxiety and depression items among young children. Journal of Psychopathology and Behavioral Assessment, 22(3), 257-270. (05.15)

Murphy, D. A., Durako, S. J., Moscicki, A. B., Vermund, S. H., Ma, Y., Schwarz, D. F., & Muenz, L. R. (2001). No change in health risk behaviors over time among HIV infected adolescents in care: role of psychological distress. Journal of Adolescent Health, 29(Suppl3), 57-63. (01.63)

Murphy, D. A., Durako, S. J., Muenz, L. R., & Wilson, C. M. (2000). Marijuana use among HIV-positive and high-risk adolescents: a comparison of self-report through audio computer-assisted self-administered interviewing and urinalysis. American Journal of Epidemiology, 152(9), 805-813. (01.72)

Murphy, D. A., Marelich, W. D., & Hoffman, D. (2000). Assessment of anxiety and depression in young children: support for two separate constructs. Journal of Clinical Child Psychology, 29(3), 383-391. (05.16)

Murphy, D. A., Marelich, W. D., & Hoffman, D. (2002). A longitudinal study of the impact on young children of maternal HIV serostatus disclosure. Clinical Child Psychology and Psychiatry, 7(1), 55-70. (01.73)

Murphy, D. A., Moscicki, A. B., Vermund, S. H., & Muenz, L. R. (2000). Psychological distress among HIV+ adolescents in the reach study: effects of life stress, social support and coping. Journal of Adolescent Health, 27(6), 391-398. (01.65)

Murphy, D. A., O'Keefe, Z. H., & Kaufman, A. H. (1999). Improving comprehension and recall of information for an HIV vaccine trial among women at risk for HIV: reading level simplification and inclusion of pictures to illustrate key concepts. AIDS Education and Prevention, 11(5), 389-399. (01.74)

Murphy, D. A., Roberts, K. J., & Hoffman, D. (2002). Stigma and ostracism associated with HIV/AIDS: Children carrying the secret of their mothers' HIV+ serostatus. Journal of Child and Family Studies, 11(2), 191-202. (01.75)

Murphy, D. A., Roberts, K. J., Hoffman, D., Molina, A., & Lu, M. C. (2003). Barriers and successful strategies to antiretroviral adherence among HIV-infected monolingual Spanish-speaking patients. AIDS Care, 15(2), 217-230. (01.89)

Murphy, D. A., Roberts, K. J., Martin, D. J., Marelich, W., & Hoffman, D. (2000). Barriers to antiretroviral adherence among HIV-infected adults. AIDS Patient Care and STD's, 14(1), 47-58. (01.67)

Murphy, D. A., Rotheram-Borus, M. J., & Joshi, V. (2000). HIV-infected adolescent and adult perceptions of tuberculosis testing, knowledge and medication adherence in the USA. AIDS Care, 12(1), 59-63. (01.76)

Murphy, D. A., Sarr, M., Durako, S. J., Moscicki, A. B., Wilson, C. M., & Muenz, L. R. (2003). Barriers to HAART adherence among human immunodeficiency virus-infected adolescents. Archives of Pediatrics and Adolescent Medicine, 157(3), 249-255. (01.90)

Murphy, D. A., Steers, W. N., & Dello Stritto, M. E. (2001). Maternal disclosure of mothers' HIV serostatus to their young children. Journal of Family Psychology, 15(3), 441-450. (01.77)

Murphy, D. A., Stein, J. A., Schlenger, W., & Maibach, E. (2001). Conceptualizing the multidimensional nature of self-efficacy: assessment of situational context and level of behavioral challenge to maintain safer sex. Health Psychology, 20(4), 281-290. (01.78)

Murphy, D. A., Wilson, C. M., Durako, S. J., Muenz, L. R., & Belzer, M. (2001). Antiretroviral medication adherence among the reach HIV-infected adolescent cohort in the USA. AIDS Care, 13(1), 27-40. (01.79)

Last updated - 02/11/2010

Top of Page

2015 ISAP Publications
2014 ISAP Biennial Report